Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

851 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation.
Widenmeyer M, Shebzukhov Y, Haen SP, Schmidt D, Clasen S, Boss A, Kuprash DV, Nedospasov SA, Stenzl A, Aebert H, Wernet D, Stevanović S, Pereira PL, Rammensee HG, Gouttefangeas C. Widenmeyer M, et al. Among authors: stenzl a. Int J Cancer. 2011 Jun 1;128(11):2653-62. doi: 10.1002/ijc.25601. Epub 2010 Oct 8. Int J Cancer. 2011. PMID: 20715115
Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.
Krüger T, Schoor O, Lemmel C, Kraemer B, Reichle C, Dengjel J, Weinschenk T, Müller M, Hennenlotter J, Stenzl A, Rammensee HG, Stevanović S. Krüger T, et al. Among authors: stenzl a. Cancer Immunol Immunother. 2005 Sep;54(9):826-36. doi: 10.1007/s00262-004-0650-5. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627209 Free PMC article.
Immunotherapy of renal cell carcinoma.
Gouttefangeas C, Stenzl A, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Among authors: stenzl a. Cancer Immunol Immunother. 2007 Jan;56(1):117-28. doi: 10.1007/s00262-006-0172-4. Epub 2006 May 5. Cancer Immunol Immunother. 2007. PMID: 16676181 Free PMC article. Review.
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Dengjel J, Nastke MD, Gouttefangeas C, Gitsioudis G, Schoor O, Altenberend F, Müller M, Krämer B, Missiou A, Sauter M, Hennenlotter J, Wernet D, Stenzl A, Rammensee HG, Klingel K, Stevanović S. Dengjel J, et al. Among authors: stenzl a. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4163-70. doi: 10.1158/1078-0432.CCR-05-2470. Clin Cancer Res. 2006. PMID: 16857787
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface.
Weinzierl AO, Lemmel C, Schoor O, Müller M, Krüger T, Wernet D, Hennenlotter J, Stenzl A, Klingel K, Rammensee HG, Stevanovic S. Weinzierl AO, et al. Among authors: stenzl a. Mol Cell Proteomics. 2007 Jan;6(1):102-13. doi: 10.1074/mcp.M600310-MCP200. Epub 2006 Oct 29. Mol Cell Proteomics. 2007. PMID: 17074750 Free article.
HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
Stickel JS, Weinzierl AO, Hillen N, Drews O, Schuler MM, Hennenlotter J, Wernet D, Müller CA, Stenzl A, Rammensee HG, Stevanović S. Stickel JS, et al. Among authors: stenzl a. Cancer Immunol Immunother. 2009 Sep;58(9):1407-17. doi: 10.1007/s00262-008-0655-6. Epub 2009 Feb 1. Cancer Immunol Immunother. 2009. PMID: 19184600 Free PMC article.
851 results